gliquidone has been researched along with Diabetes Mellitus, Type 2 in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (26.92) | 18.7374 |
1990's | 11 (42.31) | 18.2507 |
2000's | 4 (15.38) | 29.6817 |
2010's | 3 (11.54) | 24.3611 |
2020's | 1 (3.85) | 2.80 |
Authors | Studies |
---|---|
Dong, J; Liao, L; Sheng, Q; Xie, T; Xu, C; Zhang, Q; Zhang, R; Zhou, X; Zou, Z | 1 |
Arayne, MS; Sultana, N; Tabassum, A | 1 |
Hahn, M; Hammer, C; Holstein, A; Kovacs, P; Kulamadayil, NS | 1 |
Han, B; You, L | 1 |
Li, XJ; Wang, S; Yang, HY; Zhao, GZ | 1 |
Malaisse, WJ | 1 |
Albrecht, H; Hug, H; Kersten, S; Meyer, UA; Podvinec, M; Roth, A; Rücker, C; Scarsi, M; Schwede, T | 1 |
Borthwick, LJ; Wilson, S | 1 |
Akkan, AG; Malaisse, WJ; Sener, A | 1 |
Bresler, M; Grzeszczak, W; Gumprecht, J; Strojek, K; Trautsolt, W | 1 |
König, E; Limmer, J; Rupprecht, E | 1 |
Grzeszczak, W; Strojek, K | 1 |
Czekalski, S; Fuchs, H; Gruszczyńska, M; Krzyzanowska-Swiniarska, B | 1 |
Brickl, R; Eschey, H; Greischel, A; Heinzel, G; König, E; Limmer, J; Rupprecht, E; von Nicolai, H | 1 |
Leclercq-Meyer, V; Malaisse, WJ | 1 |
Benjasuratwong, Y; Deerochanawong, C; Ngawngamrat, S; Nitiyanant, W; Patanaungkul, S; Sriussadaporn, S | 1 |
Guliaeva, IV; Kurganova, TA; Mazurov, VI; Nagibovich, OA; Novik, AA; Romashevskiĭ, BV | 1 |
Chen, KW; Chou, SC; Huang, CC; Hwang, JS; Lin, JD; Lin, KD | 1 |
Krusová, D; Podrouzková, B | 1 |
Bonora, E; Cacciatori, V; Moghetti, P; Muggeo, M; Querena, M; Tosi, F; Travia, D; Zenere, M; Zoppini, G | 1 |
Bosi, E; Del Din, G; Dini, FL; Iori, I; Manicardi, E; Portioli, I | 1 |
Altomare, E; Di Reda, N; Giovine, A; Lasorsa, G; Procacci, V; Roberto, MG; Stufano, N; Vendemiale, G | 1 |
Gregorová, A; Rybka, J; Zmydlená, A | 1 |
Altomare, E; Giovine, A; Lasorsa, G; Procacci, V; Roberto, MG; Ronchi, AM; Stufano, N; Vendemiale, G | 1 |
Bocchino, C; Bonavita, M; Carleo, R; Dell'Aversano, R; Gatti, A; Giacometti, F; Monda, M | 1 |
Harrower, AD | 1 |
2 review(s) available for gliquidone and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Gliquidone contributes to improvement of type 2 diabetes mellitus management: a review of pharmacokinetic and clinical trial data.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Molecular Structure; Sulfonylurea Compounds; Treatment Outcome | 2006 |
[Gliquidone--opinions from the international literature].
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds | 1993 |
5 trial(s) available for gliquidone and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Diabetic control with gliquidone--a short acting sulphonylurea.
Topics: Adolescent; Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Glyburide; Glycated Hemoglobin; Hexosaminidases; Humans; Hypoglycemic Agents; Male; Middle Aged; Monitoring, Physiologic; Random Allocation; Sulfonylurea Compounds | 1984 |
Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
Topics: Aged; Area Under Curve; Blood Glucose; Calibration; Chromatography, High Pressure Liquid; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Half-Life; Humans; Hypoglycemic Agents; Male; Middle Aged; Quality Control; Single-Blind Method; Spectrometry, Fluorescence; Sulfonylurea Compounds | 1997 |
The efficacy and safety of gliquidone in Thai diabetics.
Topics: Adult; Aged; Aged, 80 and over; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds; Thailand | 1997 |
Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.
Topics: Administration, Oral; Adult; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucose; Hexokinase; Humans; Hypoglycemic Agents; Injections, Intravenous; Insulin; Islets of Langerhans; Leukocytes, Mononuclear; Male; Middle Aged; Receptor, Insulin; Sulfonylurea Compounds | 1992 |
Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.
Topics: Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
19 other study(ies) available for gliquidone and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Gliquidone ameliorates hepatic insulin resistance in streptozotocin-induced diabetic Sur1
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Knockout Techniques; Gluconeogenesis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Male; Rats; Rats, Transgenic; Streptozocin; Sulfonylurea Compounds; Sulfonylurea Receptors | 2021 |
RP-LC simultaneous quantitation of co-administered drugs for (non-insulin dependent) diabetic mellitus induced dyslipidemia in active pharmaceutical ingredient, pharmaceutical formulations and human serum with UV-detector.
Topics: Adult; Anticholesteremic Agents; Calibration; Chromatography, Reverse-Phase; Diabetes Mellitus, Type 2; Dyslipidemias; Fluorobenzenes; Healthy Volunteers; Humans; Hypoglycemic Agents; Limit of Detection; Male; Metformin; Pyrimidines; Quality Control; Rosuvastatin Calcium; Sulfonamides; Sulfonylurea Compounds; Ultraviolet Rays | 2013 |
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
Topics: Age Factors; Aged; Aged, 80 and over; Blood Glucose Self-Monitoring; Comorbidity; Diabetes Mellitus, Type 2; Female; Germany; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Inappropriate Prescribing; Incidence; Independent Living; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Nursing Homes; Patient Education as Topic; Prospective Studies; Sulfonylurea Compounds | 2010 |
[Effect of initial periodontal therapy on diabetic patients with chronic periodontitis].
Topics: Adult; Alveolar Bone Loss; Blood Glucose; Chronic Periodontitis; Dental Scaling; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Education as Topic; Periodontal Index; Radiography, Panoramic; Root Planing; Sulfonylurea Compounds | 2010 |
[Gliquidon induced-desensitization of pancreatic beta cells and the partial reversion of responsiveness after the desensitization of exposure to drug in normal and STZ type 2 diabetic rats].
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Rats; Rats, Wistar; Sulfonylurea Compounds; Time Factors | 2004 |
Sulfonylureas and glinides exhibit peroxisome proliferator-activated receptor gamma activity: a combined virtual screening and biological assay approach.
Topics: ATP-Binding Cassette Transporters; Computer Simulation; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Gene Expression Regulation; Glipizide; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Pioglitazone; Potassium Channels; Potassium Channels, Inwardly Rectifying; PPAR gamma; Protein Binding; Receptors, Drug; Sulfonylurea Compounds; Sulfonylurea Receptors; Thiazolidinediones | 2007 |
Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma.
Topics: Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drug Monitoring; Forensic Medicine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Reproducibility of Results; Sensitivity and Specificity; Sulfonylurea Compounds | 1995 |
[Does hypoglycemic treatment with gliclazide and gliquidone affect platelet function in type II diabetic patients?].
Topics: Adult; Aged; Blood Platelets; Diabetes Mellitus, Type 2; Gliclazide; Humans; Hypoglycemic Agents; Middle Aged; Reference Values; Sulfonylurea Compounds | 1993 |
[Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
Topics: Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Sulfonylurea Compounds | 1993 |
[Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Gliclazide; Humans; Hypoglycemic Agents; Middle Aged; Platelet Aggregation; Sulfonylurea Compounds | 1993 |
Modulation of gliquidone action by forskolin in the pancreas of normal and GK rats.
Topics: Animals; Blood Glucose; Colforsin; Diabetes Mellitus, Type 2; Glucagon; Glucose; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Perfusion; Rats; Rats, Inbred Strains; Rats, Wistar; Reference Values; Sulfonylurea Compounds; Time Factors | 1997 |
[Effect of sugar-reducing therapy on renal function in patients with type II diabetes mellitus].
Topics: Adult; Aged; beta 2-Microglobulin; Blood Glucose; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Glyburide; Humans; Hypoglycemic Agents; Kidney; Kidney Function Tests; Middle Aged; Sulfonylurea Compounds | 1998 |
The effects of glurenorm on plasma glucose and lipids in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Sulfonylurea Compounds; Weight Gain | 2000 |
[Combined therapy with insulin/gliquidone (Glurenorm) in type 2 diabetes after treatment failure using oral antidiabetic agents].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds | 1992 |
[Evaluation of the effectiveness and tolerability of gliquidone in the treatment of diabetes mellitus type II].
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds | 1989 |
[Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus].
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gliclazide; Glucose; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Sulfonylurea Compounds | 1988 |
[Clinical experience with Glurenorm in type 2 diabetics with renal insufficiency].
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypoglycemic Agents; Kidney Failure, Chronic; Male; Sulfonylurea Compounds | 1988 |
[Pharmacodynamics of second-generation sulfonylureas: dose-effect curve of gliquidone in type II diabetics].
Topics: Aged; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Sulfonylurea Compounds | 1988 |
[Evaluation of the long-term effects of the administration of gliquidone in subjects with diabetes type II].
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin; Lipids; Male; Middle Aged; Nitrogen; Sulfonylurea Compounds | 1987 |